{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:56:24Z","timestamp":1794653784239,"version":"4.9.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002069","name":"Fraternal Order of Eagles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jhepr.2026.101999","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:11:37Z","timestamp":1787242297000},"page":"101999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting circulating fatty acid-binding protein 4 ameliorates obesity-associated hepatic steatosis"],"prefix":"10.1016","volume":"8","author":[{"given":"Xingshan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Avellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longgang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himani","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Shilyansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Schnicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagirath","family":"Chaurasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin E.","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia L.","family":"Sugg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2026.101999_bib1","article-title":"The global burden of overweight-obesity and its association with economic status, benefiting from STEPs survey of WHO member states: a meta-analysis","volume":"46","author":"Islam","year":"2024","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.jhepr.2026.101999_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s40471-014-0012-6","article-title":"The obesity epidemic: the United States as a cautionary tale for the rest of the world","volume":"1","author":"Imes","year":"2014","journal-title":"Curr Epidemiol Rep"},{"key":"10.1016\/j.jhepr.2026.101999_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/ALN.0b013e3181799d45","article-title":"Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms","volume":"109","author":"Martyn","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jhepr.2026.101999_bib4","article-title":"Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the obesity medicine association and the national lipid association 2024","volume":"10","author":"Bays","year":"2024","journal-title":"Obes Pillars"},{"key":"10.1016\/j.jhepr.2026.101999_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/cancers16020259","article-title":"MASLD and the Development of HCC: pathogenesis and therapeutic challenges","volume":"16","author":"Phoolchund","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.jhepr.2026.101999_bib6","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.101999_bib7","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2026.101999_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186420","article-title":"MASH: the nexus of metabolism, inflammation, and fibrosis","volume":"135","author":"Steinberg","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2026.101999_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41573-024-01084-2","article-title":"Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)","volume":"24","author":"Do","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhepr.2026.101999_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2025.19615","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults: a review","volume":"335","author":"Tilg","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.jhepr.2026.101999_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.07.027","article-title":"SnapShot: FABP functions","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2026.101999_bib12","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1194\/jlr.R056705","article-title":"Recent insights into the biological functions of liver fatty acid binding protein 1","volume":"56","author":"Wang","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhepr.2026.101999_bib13","article-title":"Fatty acid binding protein 1 (FABP1) depletion promotes an oxidative metabolic shift in Caco-2 colorectal cancer cells","volume":"1870","author":"Borus","year":"2025","journal-title":"Biochim Biophys Acta Mol Cel Biol Lipids"},{"key":"10.1016\/j.jhepr.2026.101999_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120621","article-title":"Fatty acid binding protein 5 regulates lipogenesis and tumor growth in lung adenocarcinoma","volume":"301","author":"Garcia","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.jhepr.2026.101999_bib15","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/jdi.13735","article-title":"Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals","volume":"13","author":"Tanaka","year":"2022","journal-title":"J Diabetes Invest"},{"key":"10.1016\/j.jhepr.2026.101999_bib16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cmet.2018.07.006","article-title":"Circulating adipose fatty acid binding protein is a new link underlying obesity-associated breast\/mammary tumor development","volume":"28","author":"Hao","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2026.101999_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/biomedicines10010197","article-title":"Unveiling the role of the fatty acid binding protein 4 in the metabolic-associated fatty liver disease","volume":"10","author":"Moreno-Vedia","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jhepr.2026.101999_bib18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrendo.2015.122","article-title":"Metabolic functions of FABPs \u2013 mechanisms and therapeutic implications","volume":"11","author":"Hotamisligil","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jhepr.2026.101999_bib19","doi-asserted-by":"crossref","first-page":"12888","DOI":"10.1074\/jbc.M413788200","article-title":"The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities","volume":"280","author":"Makowski","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhepr.2026.101999_bib20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4049\/jimmunol.1601403","article-title":"Adipose fatty acid binding protein promotes saturated fatty acid-induced macrophage cell death through enhancing ceramide production","volume":"198","author":"Zhang","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jhepr.2026.101999_bib21","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.aav3722","article-title":"Targeting a ceramide double bond improves insulin resistance and hepatic steatosis","volume":"365","author":"Chaurasia","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jhepr.2026.101999_bib22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jhep.2012.10.022","article-title":"Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice","volume":"58","author":"Hoo","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101999_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71311-8","article-title":"FABP4 deficiency ameliorates alcoholic steatohepatitis in mice via inhibition of p53 signaling pathway","volume":"14","author":"Xing","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2026.101999_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166810","article-title":"FABP4 in LSECs promotes CXCL10-mediated macrophage recruitment and M1 polarization during NAFLD progression","volume":"1869","author":"Zhou","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jhepr.2026.101999_bib25","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00424-017-1976-0","article-title":"Vasculo-protective effect of BMS-309403 is independent of its specific inhibition of fatty acid-binding protein 4","volume":"469","author":"Okamura","year":"2017","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jhepr.2026.101999_bib26","article-title":"BMS309403 stimulates glucose uptake in myotubes through activation of AMP-activated protein kinase","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2026.101999_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00210-011-0667-1","article-title":"BMS309403 directly suppresses cardiac contractile function","volume":"384","author":"Look","year":"2011","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jhepr.2026.101999_bib28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1083\/jcb.201705047","article-title":"Unconventional secretion of FABP4 by endosomes and secretory lysosomes","volume":"217","author":"Villeneuve","year":"2018","journal-title":"J Cel Biol"},{"key":"10.1016\/j.jhepr.2026.101999_bib29","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2337\/db18-1367","article-title":"Unconventional secretion of adipocyte fatty acid binding protein 4 is mediated by autophagic proteins in a sirtuin-1-dependent manner","volume":"68","author":"Josephrajan","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.jhepr.2026.101999_bib30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.cmet.2013.04.012","article-title":"Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production","volume":"17","author":"Cao","year":"2013","journal-title":"Cel Metab"},{"key":"10.1016\/j.jhepr.2026.101999_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.781789","article-title":"Relationship between fatty acid binding protein 4 and liver fat in individuals at increased cardiometabolic risk","volume":"12","author":"Rodriguez-Calvo","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.jhepr.2026.101999_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13058-024-01873-y","article-title":"Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancer","volume":"26","author":"Hao","year":"2024","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.jhepr.2026.101999_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100398","article-title":"Deep learning-based H-score quantification of immunohistochemistry-stained images","volume":"37","author":"Wen","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jhepr.2026.101999_bib35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/hep4.1854","article-title":"Single-cell, single-nucleus, and spatial RNA sequencing of the human liver identifies cholangiocyte and mesenchymal heterogeneity","volume":"6","author":"Andrews","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2026.101999_bib36","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2026.101999_bib37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12672-025-02117-x","article-title":"Expression profiles of FABP4 and FABP5 in breast cancer: clinical implications and perspectives","volume":"16","author":"Jiang","year":"2025","journal-title":"Discov Oncol"},{"key":"10.1016\/j.jhepr.2026.101999_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac6336","article-title":"Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes","volume":"7","author":"Burak","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhepr.2026.101999_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1872-034X.2010.00747.x","article-title":"Carnosic acid prevents obesity and hepatic steatosis in ob\/ob mice","volume":"41","author":"Wang","year":"2011","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhepr.2026.101999_bib40","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2026.101999_bib41","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1194\/jlr.S091793","article-title":"Adipokine FABP4 integrates energy stores and counterregulatory metabolic responses","volume":"60","author":"Prentice","year":"2019","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhepr.2026.101999_bib42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5551\/jat.48710","article-title":"Fatty acid-binding protein 4 in cardiovascular and metabolic diseases","volume":"26","author":"Furuhashi","year":"2019","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jhepr.2026.101999_bib43","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1194\/jlr.M012757","article-title":"Small-molecule inhibitors of FABP4\/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity","volume":"52","author":"Lan","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhepr.2026.101999_bib44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3229","article-title":"Development trends for human monoclonal antibody therapeutics","volume":"9","author":"Nelson","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhepr.2026.101999_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jhepr.2026.101999_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/JCI182322","article-title":"Adipocyte-derived FABP4 promotes metabolism-associated steatotic liver-induced hepatocellular carcinoma by driving ITGB1-mediated beta-catenin activation","volume":"135","author":"Leung","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2026.101999_bib47","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/hep.22896","article-title":"Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease","volume":"49","author":"Milner","year":"2009","journal-title":"Hepatology"},{"issue":"Suppl","key":"10.1016\/j.jhepr.2026.101999_bib48","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.3350\/cmh.2022.0392","article-title":"Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management","volume":"29","author":"Battistella","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101999_bib49","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.3390\/jcm12237340","article-title":"Post-transplant hepatic steatosis: a condition not to overlook","volume":"12","author":"Alabdul Razzak","year":"2023","journal-title":"J Clin Med"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926002703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926002703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:40:31Z","timestamp":1793810431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555926002703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2589555926002703"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101999","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting circulating fatty acid-binding protein 4 ameliorates obesity-associated hepatic steatosis","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101999"}}